GlassScriptPhysician profile
Jeff D Kopelman
NPI 1851363055
$1,312.51
in general payments reported to CMS, 2019-2025
14 companies · $239 in 2025
The $239 reported for 2025 was less than what a typical Plastic Surgery Within The Head & Neck provider received nationally (typical 2025 total: $238).
See the full distribution for Plastic Surgery within the Head & Neck
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2020: $41.08 · 2021: $445 · 2022: $108 · 2023: $268 · 2024: $67.31 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $574.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $250.61 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $245.47 | 2019-2025 | Dupixent |
| Glaxosmithkline, LLC. | $222.71 | 2022-2025 | Nucala |
| Optinose US, INC. | $127.04 | 2019-2023 | |
| Acclarent, INC | $91.96 | 2020-2021 | |
| Arrinex, INC. | $60.49 | 2019 | |
| Stryker Corporation | $57.58 | 2019-2025 | Clarifix, Hemopore, Xpress Loprofile |
| Medtronic, INC. | $55.42 | 2021-2023 | Propel |
| Integra Lifesciences Corporation | $54.22 | 2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Hikma Pharmaceuticals USA | $43.55 | 2023 | Ryaltris |
| Smith+Nephew, INC. | $38.06 | 2021 | |
| Merck Sharp & Dohme LLC | $25.03 | 2023 | |
| Aerin Medical INC. | $21.96 | 2024 | |
| Genzyme Corporation | $18.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeff Kopelman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.